Hanmi Science Co., Ltd. (KRX: 008930)
South Korea flag South Korea · Delayed Price · Currency is KRW
32,900
+550 (1.70%)
Oct 11, 2024, 3:30 PM KST

Hanmi Science Company Description

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally.

It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult’s bowel preparation and cold medicines, and cephalosporin antibiotics.

The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems.

The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012.

Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.

Hanmi Science Co., Ltd.
Country South Korea
Founded 1973
Industry Medical Distribution
Sector Healthcare
Employees 403
CEO Jong-Hoon Lim

Contact Details

Address:
14 Wiryeseong-daero
Seoul, 05545
South Korea
Phone 82 2 410 9114
Website hanmiscience.co.kr

Stock Details

Ticker Symbol 008930
Exchange Korea Stock Exchange
Fiscal Year January - December
Reporting Currency KRW
ISIN Number KR7008930000
SIC Code 5122

Key Executives

Name Position
Jong-Hoon Lim Chief Executive Officer
Ju-Hyun Lim President and Inside Director
Chan Seob Kim Chief Financial Officer and Senior MD